American tegumentary leishmaniasis: severe side effects of pentavalent antimonial in a patient with chronic renal failure

• المؤلفون الرئيسيون: Sílvio Alencar Marques (مؤلف), Maira Renata Merlotto (مؤلف), Paulo Müller Ramos (مؤلف), Mariangela Esther Alencar Marques (مؤلف)
• التنسيق: كتاب
• منشور في: Sociedade Brasileira de Dermatologia, 2019-07-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Abstract: Pentavalent antimonials are the first-line drug treatment for American tegumentary leishmaniasis. We report on a patient with chronic renal failure on hemodialysis who presented with cutaneous lesions of leishmaniasis for four months. The patient was treated with intravenous meglumine unde...